Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01184248 · ClinicalTrials.gov registry record · NA

The Effect of Sound Stimulation on Pure-tone Hearing Threshold

A NA study of Sensorineural Hearing Loss, sponsored by Earlogic Korea.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01184248: Completed NA study of Sensorineural Hearing Loss, sponsored by Earlogic Korea.

NCT01184248 is a NA study of Sensorineural Hearing Loss that has completed, run by Earlogic Korea. The registered enrollment target is 30 participants, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01184248, a NA study of Sensorineural Hearing Loss, has completed, sponsored by Earlogic Korea.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate if sound stimulation could improve pure-tone hearing threshold. In the late 1990s, researchers discovered that acoustic stimuli slow progressive sensorineural hearing loss and exposure to a moderately augmented acoustic environment can delay the loss of auditory function. In addition, prolonged exposure to an augmented acoustic environment could improve age-related auditory changes. These ameliorative effects were shown in several types of mouse strains, as long as the acoustic environment was provided prior to the occurrence of severe hearing loss. In addition to delaying progressive hearing loss, acoustic stimuli could also protect hearing ability against damage by traumatic noise. In particular, a method called forward sound conditioning (i.e., prior exposure to moderate levels of sound) has been shown to reduce noise-induced hearing impairment in a number of mammalian species, including humans. Interestingly, recent report has suggested that low-level sound conditioning also reduces free radical-induced damage to hair cells, increases antioxidant enzyme activity, and reduces Cox-2 expression in cochlea, and can enhance cochlear sensitivity. Specifically, increased cochlear sensitivity was observed when distortion product otoacoustic emissions (DPOAEs) and compound action potentials (CAPs) were measured. In addition to forward sound conditioning, backward sound conditioning (i.e., the use of acoustic stimuli after exposure to a traumatic noise) has been shown to protect hearing ability against acoustic trauma and to prevent the cortical map reorganization induced by traumatic noise. Based on the results of animal studies, the investigators conducted a human study in 2007 and observed that sound stimulation could improve hearing ability. On average, the pure-tone hearing threshold decreased by 8.91 dB after sound stimulation for 2 weeks. In that study, however, the investigators observed only the hearing threshold c

Conditions Studied

Interventions

  • BEHAVIORAL Sound stimulation

Study Locations (1)

California

  • Earlogic Corporation - Los Angeles

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2010-05
Est. Completion 2011-01
Phase NA
Earlogic Korea

1 total trials

What the finished NCT01184248 record still lists

NCT01184248 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Sound stimulation is the first listed.

NCT01184248 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01184248 about?

NCT01184248 is a clinical study titled "The Effect of Sound Stimulation on Pure-tone Hearing Threshold". The purpose of this study is to investigate if sound stimulation could improve pure-tone hearing threshold. In the late 1990s, researchers discovered that acoustic stimuli slow progressive sensorineural hearing loss and exposure to a moderately augmented acoustic environment can delay the loss of a...

What is the current status of trial NCT01184248?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-05. Estimated completion is 2011-01.

What conditions does trial NCT01184248 study?

This clinical trial studies the following conditions: Sensorineural Hearing Loss.

What interventions are being tested in trial NCT01184248?

The interventions under investigation include: Sound stimulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01184248?

This trial is sponsored by Earlogic Korea, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01184248 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sensorineural Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01184248's enrollment target sits among peer trials

30 10th of 13 higher than 4 of 13 other Sensorineural Hearing Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sensorineural Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01184248, the US trial registry maintained by the National Library of Medicine. NCT01184248 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.